Johnson & Johnson (JNJ)

222.89
-0.62 (-0.28%)
NYSE· Last Trade: Jun 2nd, 11:07 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panicfool.com
AbbVie's shareholders can sleep easy.
Via The Motley Fool · June 2, 2026
U.S. Health Care Depth or Global Industry Reach? VHT vs. IXJfool.com
The Vanguard Health Care ETF (VHT) and the iShares Global Healthcare ETF (IXJ) both target health care stocks, but they are tailored to different investor needs. One emphasizes broad, low-cost U.S. exposure, while the other adds global reach in a sector shaped by drug pricing, patent cycles, regulation, and medical innovation.
Via The Motley Fool · June 1, 2026
Legend Biotech Conference Spotlights CARVYKTI’s Curative Potential, Earlier Usemarketbeat.com
Legend Biotech (NASDAQ:LEGN) used an investor and analyst event to highlight long-term data and physician perspectives supporting broader use of CARVYKTI, its BCMA-directed CAR T-cell therapy for multiple myeloma developed, manufactured and co-promoted with Johnson & Johnson. Chief Executive Of
Via MarketBeat · May 31, 2026
Johnson & Johnson (NYSE:JNJ): A Classic Dividend Stock for Sustainable Passive Incomechartmill.com
Via Chartmill · May 30, 2026
3 Dividend Kings That Earn Their Crown Every Quartermarketbeat.com
These 3 Dividend Kings combine decades of dividend growth with strong fundamentals, recession resistance, and long-term income potential
Via MarketBeat · May 31, 2026
How to Recession-Proof Your Retirement Income Before Summer 2026fool.com
High energy prices have investors worried about a recession; these businesses should survive the hit just fine.
Via The Motley Fool · May 30, 2026
This Dividend King Stock Just Offered a Superb Buy-the-Dip Opportunityfool.com
Walmart is facing short-term pressures that are leading investors to miss the long-term opportunity.
Via The Motley Fool · May 30, 2026
Which dow jones stocks are moving on Friday?chartmill.com
Via Chartmill · May 29, 2026
Explore the top gainers and losers within the dow jones index in today's session.chartmill.com
Via Chartmill · May 29, 2026
VYM vs. SCHD: Which U.S. Dividend ETF Is a Better Buy?fool.com
When choosing dividend ETFs, diversification is a top priority.
Via The Motley Fool · May 29, 2026
Is Johnson & Johnson Stock Outperforming the Dow?
Johnson & Johnson has outperformed the Dow Jones over the past year, and analysts remain moderately optimistic about the stock’s outlook.
Via Barchart.com · May 28, 2026
President Trump's Drug Pricing Policies Could Hurt Drugmakers' Profits. Time to Sell Pharma Stocks?fool.com
Don't be too quick to give up on the industry.
Via The Motley Fool · May 26, 2026
Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Today's Marketfool.com
Johnson & Johnson sells products that are necessities, not just nice-to-haves.
Via The Motley Fool · May 25, 2026
A Quiet Trim From LEVIN — O-I Glass Faces Bigger Questionsfool.com
O-I Glass manufactures glass containers for food and beverage makers across the Americas, Europe, and Asia Pacific.
Via The Motley Fool · May 23, 2026
Healthcare Stocks Are on Fire -- Don't Miss These Opportunitiesfool.com
The healthcare sector outperformed the rest of the market over the past week.
Via The Motley Fool · May 22, 2026
These 3 Dividend Stocks Are as Close to a Sure Thing as Investing Getsfool.com
ExxonMobil, Johnson & Johnson, and Coca-Cola are safe stocks to buy and forget.
Via The Motley Fool · May 19, 2026
3 Dividend Kings to Buy and Hold for 20 Yearsfool.com
When it comes to reliable dividend payouts, these three companies keep rewarding their long-term shareholders.
Via The Motley Fool · May 19, 2026
Meet the Dividend King With a Higher Credit Rating Than the U.S. Governmentfool.com
It has plenty of other qualities investors should take note of.
Via The Motley Fool · May 19, 2026
3 Dividend Stocks Warren Buffett Would Buy in a Market Crashfool.com
Get greedy for these blue chip dividend stocks when Wall Street gets fearful.
Via The Motley Fool · May 17, 2026
Is Bristol Myers Squibb Stock Overvalued at Nearly $60? A Reality Check for Value Investors.fool.com
This may be an excellent deal for those focused on the long game.
Via The Motley Fool · May 11, 2026
Income or Growth: Which Healthcare Stock Fits Your Portfolio Right Now?incom
It's important to look beyond near-term volatility.
Via The Motley Fool · May 11, 2026
2 Dividend Stocks That Are No-Brainer Buys in Mayfool.com
Markets are on the rise, but worries about a recession remain elevated as May gets underway.
Via The Motley Fool · May 10, 2026
These Market Signals Alarm Me, but I Still See Profit Potential in These 3 Consumer Stocksfool.com
Consumer defensive stocks with a solid dividend history could serve investors well regardless of what happens to the market.
Via The Motley Fool · May 9, 2026
3 Unstoppable Dividend King Stocks to Buy Right Now for Less Than $550fool.com
These companies pay some of the world's most bankable dividends.
Via The Motley Fool · May 8, 2026
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson?fool.com
They have combined for 118 years of consecutive dividend increases.
Via The Motley Fool · May 6, 2026